Company: LGN
Filing Date: 2025-11-03
Form Type: DRS
Source: 0001193125-25-262782
Chunk: 244

Company: Legence Corp.
Filing Date: 2025-11-03
Form: DRS
Chunk 244
---
 the date on which the balance sheet was available for issuance, and
determined that there are no significant subsequent events requiring adjustment or disclosure.

F-4

Confidential Treatment Requested by Legence Corp. Pursuant to 17 C.F.R. Section 200.83 LEGENCE CORP. BALANCE SHEET (UNAUDITED)

|                                                                                |     |   | June 30, 
     2025 |     |   | March 27, 
      2025 |
|:-------------------------------------------------------------------------------|:----|:--|---------:|:----|:--|----------:|
| Assets                                                                         |     |   |          |     |   |           |
| Current assets:                                                                |     |   |          |     |   |           |
| Cash                                                                           |     | $ |       10 |     | $ |        10 |
| Total assets                                                                   |     |   |       10 |     |   |        10 |
| Liabilities and Stockholder’s Equity                                           |     |   |          |     |   |           |
| Liabilities                                                                    |     |   |          |     |   |           |
| Total liabilities                                                              |     |   |        — |     |   |         — |
| Equity                                                                         |     |   |          |     |   |           |
| Common stock, $0.01 par value; 1,000 shares authorized, issued and outstanding |     |   |       10 |     |   |        10 |
| Total stockholder’s equity                                                     |     |   |       10 |     |   |        10 |
| Total liabilities and stockholder’s equity                                     |     | $ |       10 |     | $ |        10 |

F-5

Confidential Treatment Requested by Legence Corp.

Pursuant to 17 C.F.R. Section 200.83

LEGENCE CORP.

NOTES TO BALANCE SHEET

(UNAUDITED)

1 – Nature of Operations

Legence Corp. was incorporated in the state of Delaware on January 9, 2025 in anticipation of a potential initial
public offering (“IPO”) and related reorganization transactions. Following the IPO and the transactions related thereto, Legence Corp. will be a holding company whose sole material asset will consist of membership interests in Legence
Holdings LLC. After the consummation of the IPO and related reorganization transactions, Legence Corp. will be the managing member